Sign in

Private company

Taiho Pharmaceutical

Logo: 大鵬薬品工業株式会社, Public domain, via Wikimedia Commons3

Japanese pharmaceutical company

Taiho Pharmaceutical Co., Ltd. (大鵬薬品工業, Taihō Yakuhin Kōgyō) is a Japanese pharmaceutical company, and a subsidiary of Otsuka Holdings, which focuses on developing cancer treatments.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1963Founded1
  • Industrypharmaceutical industry1
  • HeadquartersTokyo1
  • Websitewww.taiho.co.jp
  • Legal formkabushiki gaisha1

See how the biggest companies compare on our leaderboards

Taiho Pharmaceutical headquarters 2023-05-18
Photo: Asanagi, CC0, via Wikimedia Commons4

Taiho Pharmaceutical Co., Ltd. (大鵬薬品工業, Taihō Yakuhin Kōgyō) is a Japanese pharmaceutical company, and a subsidiary of Otsuka Holdings, which focuses on developing cancer treatments.2

Corporate structure

Taiho Pharmaceutical is part of a group headed by Otsuka Holdings. 19 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Subsidiaries and ownership

Parent company

From Wikidata.1

Timeline

  1. 1963Founded Founded1

Calendar

Drug trials and FDA: recently

  1. Aug 28, 2026Phase 3 trial completed Phase 3 trial of Domvanalimab, Zimberelimab and others in Advanced Upper Gastrointestinal Tract Adenocarcinoma, run by Arcus Biosciences, Inc.: primary completion Aug 28, 2026, no results posted yet (ClinicalTrials.gov NCT05568095).5
  2. Jun 18, 2026Phase 3 trial completed Phase 3 trial of TAS-205 [Ambulatory Cohort] [Non-ambulatory Cohort] in Duchenne Muscular Dystrophy: primary completion Jun 18, 2026, no results posted yet (ClinicalTrials.gov NCT04587908).6

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6